These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 9307449)

  • 1. Creation of chimeric hearts: a tool for testing the "passenger leukocyte" hypothesis.
    Eiref SD; Zhang W; Popma SH; Shah LJ; Moore JS; Rosengard BR
    Ann Thorac Surg; 1997 Sep; 64(3):628-33. PubMed ID: 9307449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of graft-resident donor-type antigen presenting cells alters the tempo and pathogenesis of murine cardiac allograft rejection.
    Krasinskas AM; Eiref SD; McLean AD; Kreisel D; Gelman AE; Popma SH; Moore JS; Rosengard BR
    Transplantation; 2000 Aug; 70(3):514-21. PubMed ID: 10949196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
    Pollak R; Blanchard JM
    Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
    Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
    Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of cardiac xenografts in fully xenogeneic (mouse --> rat) bone marrow chimeras.
    Mohiuddin MM; Qin Y; Qian X; Meng Y; DiSesa VJ
    Ann Thorac Surg; 2001 Sep; 72(3):740-5; discussion 745-6. PubMed ID: 11565651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
    Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
    Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term immunologic tolerance induction in chimeric mice after bone marrow transplantation across major histocompatibility barriers: persistent or redeveloping immunologic responsiveness after prolonged survival.
    Sugiura K; Yasumizu R; Iwai H; Inaba MM; Toki J; Ogura M; Hara I; Good RA; Ikehara S
    Thymus; 1991 Nov; 18(3):137-53. PubMed ID: 1838450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic CD4-CDR3 peptide analog enhances bone marrow engraftment across major histocompatibility barriers.
    Koch U; Korngold R
    Blood; 1997 Apr; 89(8):2880-90. PubMed ID: 9108408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow.
    Khanna A; Antonysamy MA; Subbotin VM; Steptoe RJ; Li W; Rudert WA; Thomson AW
    Transpl Immunol; 1998 Dec; 6(4):225-34. PubMed ID: 10342736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of passenger leukocyte genotype in rejection and acceptance of rat liver allografts.
    Kreisel D; Petrowsky H; Krasinskas AM; Krupnick AS; Szeto WY; McLean AD; Popma SH; Gelman AE; Traum MK; Furth EE; Moore JS; Rosengard BR
    Transplantation; 2002 May; 73(9):1501-7. PubMed ID: 12023631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class I compatibility with pathogenic T cells.
    Ratcliffe NR; Wegmann KW; Zhao RW; Hickey WF
    J Autoimmun; 2000 Nov; 15(3):369-79. PubMed ID: 11040077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of graft-versus-host disease by induction of immune tolerance with ultraviolet B-irradiated leukocytes in H-2 disparate bone marrow donor.
    del Rosario ML; Zucali JR; Kao KJ
    Blood; 1999 May; 93(10):3558-64. PubMed ID: 10233909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor antigen-presenting cells are important in the development of obliterative airway disease.
    Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
    Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
    Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of immunological tolerance in full major and multiminor histocompatibility-disparate mice using a mixed bone marrow transplantation model.
    el Badri NS; Good RA
    Proc Soc Exp Biol Med; 1994 Jan; 205(1):67-74. PubMed ID: 8115352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.